Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab_Humira, in healthy subjects.[2017][Br J C
本文档由 崔亚杰 分享于2017-02-03 22:57
Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab_Humira, in healthy subjects.[2017][Br J C
下载文档
收藏
打印
君，已阅读到文档的结尾了呢~~